NCT01931189View on ClinicalTrials.gov

Pharmacokinetics Study of NI-071

PHASE1CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Healthy
Interventions
BIOLOGICAL

NI-071

100mg/vial

BIOLOGICAL

Infliximab

100mg/vial

Trial Locations (1)

Unknown

NichiIko Investigational Site, Tokyo

Sponsors
All Listed Sponsors
lead

Nichi-Iko Pharmaceutical Co., Ltd.

INDUSTRY

NCT01931189 - Pharmacokinetics Study of NI-071 | Biotech Hunter | Biotech Hunter